Cephalon Wants FCA Off-Label Marketing Claims Axed
By Matt Fair ( March 31, 2015, 5:20 PM EDT) -- Pharmaceutical company Cephalon Inc. urged a Pennsylvania federal judge on Tuesday to nix a pair of whistleblower suits accusing it of spurring false reimbursement claims to the government through a scheme to promote three of its drugs off-label....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.